Rui Lin Song

Rui Lin Song is currently the Executive Chairman at China Pharmaceutical Industry Research & Dev.
Association.
He also holds current positions as an Independent Non-Executive Director at Simcere Pharmaceutical Group Ltd., a Non-Executive Director at Luye Pharma Group Ltd., an Independent Director at Shenzhen Chipscreen Biosciences Co., Ltd., an Executive Director at China Chamber of International Commerce, a Director at China Pharmaceutical Industry Association, an Independent Non-Executive Director at Shanghai Henlius Biotech, Inc., an Independent Non-Executive Director at Mediwelcome Healthcare Management & Technology, Inc., an Independent Non-Executive Director at Jacobio Pharmaceuticals Group Co., Ltd., a Council Member at Chinese Pharmaceutical Association, the President at China Pharmaceutical Innovation & Research Development Assoc, and a Council Member at Bethune Charitable Foundation.
Dr. Song's former positions include being an Independent Director at Chongqing Taiji Industry (Group) Co., Ltd., an Independent Director at China Resources Boya Bio-pharmaceutical Group Co., Ltd., an Independent Director at Zhejiang Jolly Pharmaceutical Co., Ltd., a Deputy Director-Legislative Affairs Office at The State Council of the PRC, an Independent Director at Jointown Pharmaceutical Group Co., Ltd., an Independent Director at Shanxi Zhendong Pharmaceutical Co., Ltd., an Independent Director at Jiangsu Aosaikang Pharmaceutical Co. Ltd., and an Independent Director at Tibet Aim Pharm., Inc.Dr. Song's education history includes a graduate degree from China Europe International Business School in 2004, an undergraduate degree from China University of Political Science & Law in 1985, and a doctorate degree from China Pharmaceutical University in 2018.